Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses-Reference-Cited by-同舟云学术

Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

Published:2018-07-23 Issue:8 Volume:24 Page:1143-1150
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Cañadas Israel,Thummalapalli Rohit,Kim Jong Wook,Kitajima Shunsuke,Jenkins Russell William^ORCID,Christensen Camilla Laulund,Campisi Marco^ORCID,Kuang Yanan,Zhang Yanxi,Gjini Evisa,Zhang Gao,Tian Tian,Sen Debattama Rai.,Miao Diana^ORCID,Imamura Yu,Thai Tran,Piel Brandon,Terai Hideki,Aref Amir Reza,Hagan Timothy,Koyama Shohei,Watanabe Masayuki,Baba Hideo,Adeni Anika Elise,Lydon Christine Anne,Tamayo Pablo^ORCID,Wei Zhi^ORCID,Herlyn Meenhard,Barbie Thanh Uyen,Uppaluri Ravindra,Sholl Lynnette Marie,Sicinska Ewa,Sands Jacob,Rodig Scott,Wong Kwok Kin,Paweletz Cloud Peter,Watanabe Hideo,Barbie David Allen

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-018-0116-5.pdf

Reference38 articles.

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646–674 (2011).

2. Marusyk, A. et al. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 514, 54–58 (2014).

3. Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346–354 (2013).

4. Tabassum, D. P. & Polyak, K. Tumorigenesis: It takes a village. Nat. Rev. Cancer 15, 473–483 (2015).

5. Konieczkowski, D. J. et al. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 4, 816–827 (2014).

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT/BCL-6/ABCA1 axis;Phytomedicine;2024-10

2. Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors;Molecular Oncology;2024-09-11

3. Endogenous retroviruses activate MARCO-mediated inflammatory response to block retroviral infection;2024-09-05

4. Suppression of double-stranded RNA sensing in cancer: molecular mechanisms and therapeutic potential;Biochemical Society Transactions;2024-09-02

5. Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer;Cancer Research Communications;2024-09-01